Table 3.
Expression Profile of IL-4, IL-17 and CD163 in Different Grades of Hepatic Steatosis in Liver Sections of Chronic Hepatitis C
| IL4 Expression | IL-17 Expression | CD163 Expression | Total (n.) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Negative n. (%) |
Low n. (%) |
High n. (%) |
Negative n. (%) | High n. (%) |
High n. (%) |
Negative n. (%) |
Low n. (%) |
High n. (%) |
|||
| Hepatic Steatosis | mild | 8a 66.66) | 2b (16.67) | 2b (16.67) | 3a (25) | 7b (58.33) | 2b (16.67) | 6a (50) | 2a (16.67) | 4a (33.33) | 12 |
| moderate | 5a (16.67) | 10b (33.33) | 15a, b(50) | 2a(6.67) | 8b (26.66) | 20a, b (60.67) | 9a (30) | 8a (26.67) | 13a (43.33) | 30 | |
| marked | 1a, b (5.55) | 3b(16.67) | 14 (77.78) | 0a, b(0) | 0b (0) | 18a (100) | 7a (38.88) | 4a, b (22.22) | 7b (38.88) | 18 | |
| Total | 14 (23.33) | 15 (25) | 31 (51.67) | 5(8.3) | 15 (25) | 40 (66.7) | 22 (36.7) | 14 (23.3) | 24 (40) | 60 | |
Each subscript letter denotes a subset of IL17 Intensity categories whose column proportions do not differ significantly from each other at the 0.05 level